Literature DB >> 14551675

Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.

A Papaioannou1, W Parkinson, N Ferko, L Probyn, G Ioannidis, E Jurriaans, G Cox, R J Cook, D Kumbhare, J D Adachi.   

Abstract

PURPOSE: Patients with chronic obstructive pulmonary disease (COPD) may be at higher risk for osteoporosis. The primary objective of this case-control study was to determine the prevalence of vertebral fractures among patients with COPD admitted to acute care compared with a gender- and age-matched control group. SUBJECTS AND METHODS: Subjects were identified by chart reviews from an acute care hospital in Hamilton, Ontario, in 1999, including patients who were over 50 years old. In total, 127 patients with ICD-9 codes specifying COPD were randomly selected and compared with 127 gender- and age-matched controls. Chest radiographs were interpreted by two radiologists who defined and graded vertebral fractures using Genant's method. Medications taken, or prescribed at discharge, were recorded from charts.
RESULTS: The overall prevalence of at least one vertebral fracture was found to be 34/127 (26.8%) in the COPD patients compared with 30/127 (23.6%) in the controls ( p=0.556). A significantly greater proportion of COPD patients had at least one severe vertebral fracture (OR=3.75, 95% CI 1.24 to 11.3). Review of hospital chest X-ray reports indicated that only 12 of 64 (18.8%) patients with vertebral fractures identified by the study radiologists actually had a vertebral fracture noted in the report. The proportion of COPD patients with vertebral fractures who were discharged on osteoporosis therapy was 5/27 (18.5%). There was a suggestion of lower lung function, as measured by forced vital capacity (FVC%), in patients with severe vertebral fractures ( p=0.067).
CONCLUSIONS: These data indicate that: (1) There is an increased proportion of COPD patients with severe vertebral fracture, and (2) Documentation and treatment of osteoporosis in acute care COPD patients is low. Therefore, there is a need to target this high-risk group for osteoporosis screening and potential clinical management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551675     DOI: 10.1007/s00198-003-1449-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  19 in total

1.  Vertebral fractures.

Authors:  C Cooper; L J Melton
Journal:  BMJ       Date:  1992-03-28

Review 2.  Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.

Authors:  M F Goldstein; J J Fallon; R Harning
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

3.  Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions.

Authors:  A Papaioannou; J D Adachi; W Parkinson; G Stephenson; M Bédard
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Epidemiology of vertebral fractures in women.

Authors:  L J Melton; S H Kan; M A Frye; H W Wahner; W M O'Fallon; B L Riggs
Journal:  Am J Epidemiol       Date:  1989-05       Impact factor: 4.897

Review 5.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

6.  Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.

Authors:  L J Walsh; C A Wong; J Oborne; S Cooper; S A Lewis; M Pringle; R Hubbard; A E Tattersfield
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

7.  Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.

Authors:  C E McEvoy; K E Ensrud; E Bender; H K Genant; W Yu; J M Griffith; D E Niewoehner
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

8.  Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  D M Kado; W S Browner; L Palermo; M C Nevitt; H K Genant; S R Cummings
Journal:  Arch Intern Med       Date:  1999-06-14

9.  Relationship of lung function to severity of osteoporosis in women.

Authors:  J A Leech; C Dulberg; S Kellie; L Pattee; J Gay
Journal:  Am Rev Respir Dis       Date:  1990-01

10.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

View more
  33 in total

1.  Idiopathic pulmonary fibrosis a rare disease with severe bone fragility.

Authors:  Carla Caffarelli; Stefano Gonnelli; Maria Dea Tomai Pitinca; Valentina Francolini; Annalisa Fui; Elena Bargagli; Rosa Metella Refini; David Bennett; Ranuccio Nuti; Paola Rottoli
Journal:  Intern Emerg Med       Date:  2016-07-08       Impact factor: 3.397

2.  Whole body vibration therapy in fracture prevention among adults with chronic disease.

Authors:  Marco Yc Pang
Journal:  World J Orthop       Date:  2010-11-18

3.  Factors associated with the lumbar spine and proximal femur bone mineral density in older men.

Authors:  Jane A Cauley; Robin L Fullman; Katie L Stone; Joseph M Zmuda; Douglas C Bauer; Elizabeth Barrett-Connor; Kristine Ensrud; Edith M C Lau; Eric S Orwoll
Journal:  Osteoporos Int       Date:  2005-05-11       Impact factor: 4.507

4.  Bone mineral density in patients with obstructive sleep apnea syndrome.

Authors:  Hulya Uzkeser; Kadir Yildirim; Bulent Aktan; Saliha Karatay; Hasan Kaynar; Omer Araz; Korhan Kilic
Journal:  Sleep Breath       Date:  2012-04-02       Impact factor: 2.816

Review 5.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 6.  Exercise for improving outcomes after osteoporotic vertebral fracture.

Authors:  Lora M Giangregorio; Norma J Macintyre; Lehana Thabane; Carly J Skidmore; Alexandra Papaioannou
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

7.  Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function.

Authors:  Reiko Watanabe; Takeshi Tanaka; Keisuke Aita; Masaaki Hagiya; Toshiaki Homma; Kyoko Yokosuka; Hisami Yamakawa; Tsutomu Yarita; Nobuyuki Tai; Junko Hirano; Daisuke Inoue; Ryo Okazaki
Journal:  J Bone Miner Metab       Date:  2014-07-05       Impact factor: 2.626

8.  Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.

Authors:  D Brask-Lindemann; P Eiken; P Eskildsen; B Abrahamsen
Journal:  Osteoporos Int       Date:  2012-11-14       Impact factor: 4.507

9.  Scores on the Safe Functional Motion test predict incident vertebral compression fracture.

Authors:  N J MacIntyre; C P Recknor; S L Grant; J C Recknor
Journal:  Osteoporos Int       Date:  2013-08-03       Impact factor: 4.507

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.